Ronald Blue Trust, Inc. Bausch Health Companies Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 88 shares of BHC stock, worth $650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88
Previous 64
37.5%
Holding current value
$650
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
254Shares Held
253MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$257 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$217 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$195 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$116 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$96.1 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.67B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...